Barely Significant
← all phrases

“a nonsignificant trend”

5,407 sentences · 5,407 papers · 7,516 search hits before verification · confirmed specimen

Sighted at

p<0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

We also noted increased WNT5A expression in IDH-mutant, ATRX-deficient gliomas (astrocytomas) compared to IDH-mutant, ATRX-intact gliomas (oligodendrogliomas) in transcriptional data from the TCGA and the CGGA, with a nonsignificant trend to higher expression also seen in transcriptional data from the GLASS Consortium ( Supplementary Fig.
Furthermore, the average plasma levels of bilirubin (total and conjugated bilirubin) were significantly increased by three- to sixfold in CDAHFD-fed minipigs after 2, 4, and 5 mo on CDAHFD ( Table 1 ), and a nonsignificant trend toward decreased plasma levels of iron were also observed in minipigs on CDAHFD ( Table 1 ).
The Seattle–King County study reported a nonsignificant trend toward higher INH-related hepatotoxicity in women compared with men, although the incidence of severe hepatotoxicity was relatively low in both men and women. 23 The USPHS study showed no overall difference between women and men in rates of probable INH hepatotoxicity. 7 The San Diego and Memphis s
Ruxolitinib was associated with a nonsignificant trend towards improved PV ‐related symptoms versus hydroxycarbamide, although an unexpectedly large proportion of patients who maintained their hydroxycarbamide dose reported symptom improvement. polycythaemia vera quality of life signs and symptoms Janus kinase hydroxycarbamide Incyte Corporation Treatment dose modifications were permitted for safety and efficacy and to optimize response for each patient.
In the FOXTROT trial, a randomized controlled trial evaluating the efficacy of neoadjuvant chemotherapy in locally advanced colon cancer, a few patients underwent SEMS placement as a bridge to surgery, and the results showed a significant decrease in the R1 resection rate and a nonsignificant trend toward better oncological outcomes at two years[ 70 ].
] Nevertheless, data regarding the effects of HRT in post-menopausal women have been contradictory.[ 56 – 58 ] More recently, larger randomized controlled trials from the Women’s Health Initiative have found no difference in PAD outcomes with conjugated equine estrogens versus placebo, albeit with a nonsignificant trend towards an increase in peripheral arterial events.[ 56 ] These data suggest that, although HRT does not appear to reduce the odds of developing PAD in postmenopausal females, taking exogenous estrogen may instead potentially increase the risk of morbidity from vascular events.[ 56 ] Other large, we